Breaking
•BREAKING: Naresh Bhatt guilty of murdering wife Mamta Kafle Bhatt - InsideNoVa•Republican-led House rejects Hegseth impeachment effort - NBC News•Drug price hikes in Germany could cost health insurers extra $6.2 billion annually, study finds - Reuters•BlackRock's John Kelly talks investment environment, job market and more in wake of blue wave | POLITICO at B20 USA - Politico•Teaching climate change changes how I teach - LSE Higher Education - LSE Blogs•ExxonMobil CEO to Miss UN Climate Talks After Three Years - Bloomberg.com•Can the Blue Wave Turn the Tide Against Border Wall Construction in Texas? - Inside Climate News•NHL rumblings: Bettman on Russia and World Cup, plus latest on Hughes, Larkin, Michkov, more - The New York Times•Notre Dame-Miami showdown drives social media buzz as Irish take No. 1 spot - Sports Business Journal•Blue Jays GM breaks silence on controversial Anthony Santander posts - Yahoo Sports•Insiders Reveal Michigan’s Quarterback Plan for Oregon - Yahoo Sports•Seattle Seahawks sign rookie DT to practice squad - Seattle Sports•Earnings call transcript: SenesTech tops Q3 2026 estimates, shares fall By Investing.com - Investing.com UK•Pete Hegseth impeachment effort averted by US House Republicans - The Jerusalem Post•US justice department sues Lyft over alleged refusal to serve passengers with disabilities - The Guardian•On Co-CEO Says Asia-Pacific Region Is ‘Match Made in Heaven’ for Its Premium Positioning, But Will Controversy Get in the Way? - Yahoo Finance•QTI: 75% Q3 revenue growth, with Medicare coverage advancing and Middle East delays trimming FY2026 guidance - TradingView•Yili surpasses EU raw milk standards after more than 20 years - Yahoo Finance•Pentagon Hegseth Impeachment - Columbia Missourian•‘Power Trip’: Nebula Sets Theatrical Release For Short From ‘American Beauty’ Producer Dan Jinks•BREAKING: Naresh Bhatt guilty of murdering wife Mamta Kafle Bhatt - InsideNoVa•Republican-led House rejects Hegseth impeachment effort - NBC News•Drug price hikes in Germany could cost health insurers extra $6.2 billion annually, study finds - Reuters•BlackRock's John Kelly talks investment environment, job market and more in wake of blue wave | POLITICO at B20 USA - Politico•Teaching climate change changes how I teach - LSE Higher Education - LSE Blogs•ExxonMobil CEO to Miss UN Climate Talks After Three Years - Bloomberg.com•Can the Blue Wave Turn the Tide Against Border Wall Construction in Texas? - Inside Climate News•NHL rumblings: Bettman on Russia and World Cup, plus latest on Hughes, Larkin, Michkov, more - The New York Times•Notre Dame-Miami showdown drives social media buzz as Irish take No. 1 spot - Sports Business Journal•Blue Jays GM breaks silence on controversial Anthony Santander posts - Yahoo Sports•Insiders Reveal Michigan’s Quarterback Plan for Oregon - Yahoo Sports•Seattle Seahawks sign rookie DT to practice squad - Seattle Sports•Earnings call transcript: SenesTech tops Q3 2026 estimates, shares fall By Investing.com - Investing.com UK•Pete Hegseth impeachment effort averted by US House Republicans - The Jerusalem Post•US justice department sues Lyft over alleged refusal to serve passengers with disabilities - The Guardian•On Co-CEO Says Asia-Pacific Region Is ‘Match Made in Heaven’ for Its Premium Positioning, But Will Controversy Get in the Way? - Yahoo Finance•QTI: 75% Q3 revenue growth, with Medicare coverage advancing and Middle East delays trimming FY2026 guidance - TradingView•Yili surpasses EU raw milk standards after more than 20 years - Yahoo Finance•Pentagon Hegseth Impeachment - Columbia Missourian•‘Power Trip’: Nebula Sets Theatrical Release For Short From ‘American Beauty’ Producer Dan Jinks
TheNewsPulse.pro
Home/clinical trials/diseases/drugs
clinical_trials

Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows

Confidence86·multiple reportsImportance88NP-EVT-20261110-78F7F76

(MedPage Today) -- One dose of a novel small interfering RNA (siRNA) therapy -- CIDEBsiRNA (also known as ALN-CIDEB) -- led to normal liver fat content and lower alanine aminotransferase (ALT) levels in most patients with metabolic dysfunction...

Read the original at the primary source
Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows
11/10/2026, 10:07:14 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —